Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (353)
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
CTT PHARMACEUTICAL HOLDINGS, INC. — Director
Shares
10,100
Price
$0.04
Total Value
$454.50
Shares Held After
1,056,800
% of Holdings
1.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
533
Price
$95.75
Total Value
$51.03K
Shares Held After
14,219
% of Holdings
3.6%
CYBIN INC. (CYBN)
Halstead Michael — Chief Executive Officer
Shares
100,000
Price
$13.47
Total Value
$1.35M
Shares Held After
168,568
% of Holdings
59.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,667
Price
$95.31
Total Value
$254.20K
Shares Held After
29,995
% of Holdings
8.2%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
601
Price
$94.44
Total Value
$56.76K
Shares Held After
32,662
% of Holdings
1.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,832
Price
$93.32
Total Value
$357.59K
Shares Held After
33,263
% of Holdings
10.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,900
Price
$92.37
Total Value
$267.87K
Shares Held After
37,095
% of Holdings
7.3%
Heartflow, Inc. (HTFL)
Rogers Campbell — Chief Medical Officer
Shares
19,682
Price
$50.15
Total Value
$987.05K
Shares Held After
79,956
% of Holdings
19.8%
Bolt Biotherapeutics, Inc. (BOLT)
Quinn William P. — Director
Shares
9,132
Price
$3.24
Total Value
$29.55K
Shares Held After
25,384
% of Holdings
26.5%
Bolt Biotherapeutics, Inc. (BOLT)
Nemec Sarah — Senior VP, Finance and PAO
Shares
4,077
Price
$3.24
Total Value
$13.19K
Shares Held After
17,082
% of Holdings
19.3%
Bolt Biotherapeutics, Inc. (BOLT)
Yonehiro Grant — Chief Operating Officer
Shares
6,850
Price
$3.24
Total Value
$22.17K
Shares Held After
17,269
% of Holdings
28.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$498.25
Total Value
$79.72K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
277
Price
$496.64
Total Value
$137.57K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,330
Price
$495.66
Total Value
$1.15M
Shares Held After
324,880
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,269
Price
$494.70
Total Value
$2.11M
Shares Held After
327,210
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,216
Price
$493.78
Total Value
$1.09M
Shares Held After
331,479
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
248
Price
$492.91
Total Value
$122.24K
Shares Held After
333,695
% of Holdings
0.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.43
Total Value
$843.46K
Shares Held After
927,000
% of Holdings
10.8%
NovaBridge Biosciences (NBP)
Dennis Phillip Andrew — Chief Medical Officer
Shares
8,209
Price
$0.71
Total Value
$5.83K
Shares Held After
173,427
% of Holdings
4.5%
CHEMED CORP (CHE)
MCNAMARA KEVIN J — Director
Shares
2,000
Price
$501.40
Total Value
$1.00M
Shares Held After
68,418
% of Holdings
2.8%
Heartflow, Inc. (HTFL)
Verghese Vikram — Chief Financial Officer
Shares
16,766
Price
$50.75
Total Value
$850.93K
Shares Held After
155,183
% of Holdings
9.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
30,000
Price
$96.22
Total Value
$2.89M
Shares Held After
489,209
% of Holdings
5.8%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
35,852
Price
$43.05
Total Value
$1.54M
Shares Held After
13,115
% of Holdings
73.2%
CRESCENT BIOPHARMA, INC. (CBIO)
Brumm Joshua T — Director
Shares
7,837
Price
$16.71
Total Value
$130.96K
Shares Held After
271,765
% of Holdings
2.8%
CRESCENT BIOPHARMA, INC. (CBIO)
McNeill Jonathan — President and COO
Shares
3,839
Price
$16.71
Total Value
$64.15K
Shares Held After
134,588
% of Holdings
2.8%
Nutex Health Inc. (NUTX)
Saunders Scott J — Director
Shares
203
Price
$214.25
Total Value
$43.49K
Shares Held After
400
% of Holdings
33.7%
Sionna Therapeutics, Inc. (SION)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
33,800
Price
$7.46
Total Value
$252.15K
Shares Held After
3,448,812
% of Holdings
1.0%
Sionna Therapeutics, Inc. (SION)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
3,415,011
Price
$6.32
Total Value
$21.58M
Shares Held After
3,482,612
% of Holdings
49.5%
CRISPR Therapeutics AG (CRSP)
Behbahani Ali — Director
Shares
13,679
Price
$57.09
Total Value
$780.94K
Shares Held After
16,637
% of Holdings
45.1%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
5,840
Price
$110.29
Total Value
$644.11K
Shares Held After
700
% of Holdings
89.3%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
2,920
Price
$110.31
Total Value
$322.10K
Shares Held After
6,540
% of Holdings
30.9%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
6,968
Price
$110.30
Total Value
$768.56K
Shares Held After
9,460
% of Holdings
42.4%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
19,384
Price
$110.36
Total Value
$2.14M
Shares Held After
16,428
% of Holdings
54.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,279
Price
$69.57
Total Value
$88.98K
Shares Held After
495,686
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,721
Price
$69.01
Total Value
$601.87K
Shares Held After
496,965
% of Holdings
1.7%
Bolt Biotherapeutics, Inc. (BOLT)
Quinn William P. — Director
Shares
6,545
Price
$3.32
Total Value
$21.72K
Shares Held After
34,516
% of Holdings
15.9%
Bolt Biotherapeutics, Inc. (BOLT)
Nemec Sarah — Senior VP, Finance and PAO
Shares
2,922
Price
$3.32
Total Value
$9.70K
Shares Held After
21,159
% of Holdings
12.1%
Bolt Biotherapeutics, Inc. (BOLT)
Yonehiro Grant — Chief Operating Officer
Shares
4,909
Price
$3.32
Total Value
$16.29K
Shares Held After
24,119
% of Holdings
16.9%
Schrodinger, Inc. (SDGR)
Akinsanya Karen — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Shares
21,599
Price
$30.00
Total Value
$647.97K
Shares Held After
69,956
% of Holdings
23.6%
Schrodinger, Inc. (SDGR)
Akinsanya Karen — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Shares
10,000
Price
$28.00
Total Value
$280.00K
Shares Held After
91,555
% of Holdings
9.8%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
240
Price
$51.48
Total Value
$12.36K
Shares Held After
25,000
% of Holdings
1.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,844
Price
$50.71
Total Value
$93.51K
Shares Held After
25,240
% of Holdings
6.8%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,916
Price
$50.03
Total Value
$145.89K
Shares Held After
27,084
% of Holdings
9.7%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
289
Price
$51.49
Total Value
$14.88K
Shares Held After
38,000
% of Holdings
0.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
2,194
Price
$50.72
Total Value
$111.27K
Shares Held After
38,289
% of Holdings
5.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
3,535
Price
$50.03
Total Value
$176.85K
Shares Held After
40,483
% of Holdings
8.0%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
10,880
Price
$620.40
Total Value
$6.75M
Shares Held After
504,273
% of Holdings
2.1%
Pharvaris N.V. (PHVS)
Lu Peng — President
Shares
100,000
Price
$35.00
Total Value
$3.50M
Shares Held After
64,953
% of Holdings
60.6%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
200,000
Price
$35.00
Total Value
$7.00M
Shares Held After
115,167
% of Holdings
63.5%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
869
Price
$163.39
Total Value
$141.99K
Shares Held After
620,589
% of Holdings
0.1%
Showing 1–50 of 353 transactions (page 1 of 8)